Kim S - Search Results

1

GV1001 reduces neurodegeneration and prolongs lifespan in 3xTg-AD mouse model through anti-aging effects.

Park HH, Kwon HS, Lee KY, Kim YE, Son JW, Choi NY, Han MH, Park DW, Kim S, Koh SH. Park HH, et al. Among authors: kim s, kim ye. Aging (Albany NY). 2024 Jan 31;16(3):1983-2004. doi: 10.18632/aging.205489. Epub 2024 Jan 31. Aging (Albany NY). 2024. PMID: 38301041 Free PMC article.

2

GV1001 Inhibits the Severity of the Ligature-Induced Periodontitis and the Vascular Lipid Deposition Associated with the Periodontitis in Mice.

Kim SY, Kim YJ, Kim S, Momeni M, Lee A, Treanor A, Kim S, Kim RH, Park NH. Kim SY, et al. Among authors: kim yj, kim s, kim rh. Int J Mol Sci. 2023 Aug 8;24(16):12566. doi: 10.3390/ijms241612566. Int J Mol Sci. 2023. PMID: 37628753 Free PMC article.

3

hTERT peptide fragment GV1001 demonstrates radioprotective and antifibrotic effects through suppression of TGF‑β signaling.

Chen W, Shin KH, Kim S, Shon WJ, Kim RH, Park NH, Kang MK. Chen W, et al. Among authors: kim s, kim rh. Int J Mol Med. 2018 Jun;41(6):3211-3220. doi: 10.3892/ijmm.2018.3566. Epub 2018 Mar 14. Int J Mol Med. 2018. PMID: 29568955 Free PMC article.

4

Retrospective Analysis of the Clinical Characteristics of Patients with Breast Cancer Treated with Telomerase Peptide Immunotherapy Combined with Cytotoxic Chemotherapy.

Kim JY, Yang DW, Kim S, Choi JG. Kim JY, et al. Among authors: kim s. Breast Cancer (Dove Med Press). 2023 Dec 21;15:955-966. doi: 10.2147/BCTT.S431333. eCollection 2023. Breast Cancer (Dove Med Press). 2023. PMID: 38146419 Free PMC article.

5

Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adenocarcinoma having high serum eotaxin levels (KG4/2015): an open-label, randomised, Phase 3 trial.

Jo JH, Kim YT, Choi HS, Kim HG, Lee HS, Choi YW, Kim DU, Lee KH, Kim EJ, Han JH, Lee SO, Park CH, Choi EK, Kim JW, Cho JY, Lee WJ, Moon HR, Park MS, Kim S, Song SY. Jo JH, et al. Among authors: kim hg, kim du, kim ej, kim s, kim yt, kim jw. Br J Cancer. 2024 Jan;130(1):43-52. doi: 10.1038/s41416-023-02474-w. Epub 2023 Oct 30. Br J Cancer. 2024. PMID: 37903909 Free PMC article. Clinical Trial.

6

Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adenocarcinoma having high serum eotaxin levels (KG4/2015): an open-label, randomised, Phase 3 trial.

Jo JH, Kim YT, Choi HS, Kim HG, Lee HS, Choi YW, Kim DU, Lee KH, Kim EJ, Han JH, Lee SO, Park CH, Choi EK, Kim JW, Cho JY, Lee WJ, Moon HR, Park MS, Kim S, Song SY. Jo JH, et al. Among authors: kim hg, kim du, kim ej, kim s, kim yt, kim jw. Br J Cancer. 2024 Jan;130(1):163. doi: 10.1038/s41416-023-02520-7. Br J Cancer. 2024. PMID: 38049557 Free PMC article. No abstract available.

7

Loss of IQSEC3 Disrupts GABAergic Synapse Maintenance and Decreases Somatostatin Expression in the Hippocampus.

Kim S, Kim H, Park D, Kim J, Hong J, Kim JS, Jung H, Kim D, Cheong E, Ko J, Um JW. Kim S, et al. Cell Rep. 2024 May 14;43(5):114254. doi: 10.1016/j.celrep.2024.114254. Online ahead of print. Cell Rep. 2024. PMID: 38748876 No abstract available.

8

Structure-Dependent Water Responsiveness of Protein Block Copolymers.

Kronenberg J, Jung Y, Chen J, Kulapurathazhe MJ, Britton D, Kim S, Chen X, Tu RS, Montclare JK. Kronenberg J, et al. Among authors: kim s. ACS Appl Bio Mater. 2024 May 15. doi: 10.1021/acsabm.4c00045. Online ahead of print. ACS Appl Bio Mater. 2024. PMID: 38748757

9

Two-Dimensional Tunneling Memtransistor with Thin-Film Heterostructure for Low-Power Logic-in-Memory Complementary Metal-Oxide Semiconductor.

Zou T, Heo S, Byeon G, Yoo S, Kim M, Reo Y, Kim S, Liu A, Noh YY. Zou T, et al. Among authors: kim s. ACS Nano. 2024 May 15. doi: 10.1021/acsnano.4c02711. Online ahead of print. ACS Nano. 2024. PMID: 38748609

10

Examining the Effectiveness of Interactive Webtoons for Premature Birth Prevention: Protocol for a Randomized Controlled Trial.

Kim SH, De Gagne JC. Kim SH, et al. JMIR Res Protoc. 2024 May 15;13:e58326. doi: 10.2196/58326. JMIR Res Protoc. 2024. PMID: 38748471 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

119,360 results

Search Page